Terms: = Brain cancer AND FCGR2B, FCGR2, 2213, ENSG00000072694, CD32, CD32B, P31994, IGFR2, FCG2 AND Prognosis
2 results:
1. An immunosuppressed microenvironment distinguishes lateral ventricle-contacting glioblastomas.
Bartkowiak T; Lima SM; Hayes MJ; Mistry AM; Brockman AA; Sinnaeve J; Leelatian N; Roe CE; Mobley BC; Chotai S; Weaver KD; Thompson RC; Chambless LB; Ihrie RA; Irish JM
JCI Insight; 2023 Jun; 8(12):. PubMed ID: 37192001
[TBL] [Abstract] [Full Text] [Related]
2. Gene expression-based biomarkers designating glioblastomas resistant to multiple treatment strategies.
Menyhárt O; Fekete JT; Győrffy B
Carcinogenesis; 2021 Jun; 42(6):804-813. PubMed ID: 33754151
[TBL] [Abstract] [Full Text] [Related]
